Laminin-332 cleavage by matriptase alters motility parameters of prostate cancer cells.
about
Laminin 332 processing impacts cellular behaviorA new method to assay protease based on amyloid misfolding: application to prostate cancer diagnosis using a panel of proteases biomarkersMatrix-dependent regulation of AKT in Hepsin-overexpressing PC3 prostate cancer cells.Androgen receptor non-nuclear regulation of prostate cancer cell invasion mediated by Src and matriptase.Imaging a functional tumorigenic biomarker in the transformed epitheliumType II transmembrane serine proteases as potential targets for cancer therapy.Components of cell-matrix linkage as potential new markers for prostate cancer.Function and clinical relevance of kallikrein-related peptidases and other serine proteases in gynecological cancers.The basal chorionic trophoblast cell layer: An emerging coordinator of placenta development.Decreasing the ratio of matriptase/HAI‑1 by downregulation of matriptase as a potential adjuvant therapy in ovarian cancer.Impact of suppression of tumorigenicity 14 (ST14)/serine protease 14 (Prss14) expression analysis on the prognosis and management of estrogen receptor negative breast cancer.Human Epididymis Protein 4 Promotes Events Associated with Metastatic Ovarian Cancer via Regulation of the Extracelluar Matrix.MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy.
P2860
Q27021764-6E096F0A-9C60-4FEB-AD45-24C24A2BCF52Q30437769-2BA0DD33-2945-47CB-978D-679D120DE479Q35095228-178B0963-6023-4AA5-9279-99AA07AB707CQ35740095-C747F228-BE75-42A7-BC45-6B6ACEC1A63CQ36512410-D99C753E-ADF7-4851-B471-D301A4F60F84Q37168351-1FAA06FE-E930-45AA-ABF7-00485FD814D6Q38161339-09086B8F-295A-40FC-B0DA-E3CA52FFCE12Q38184632-D8181B8E-3F19-4585-A6F5-B61DB987AE33Q38700458-5E3ECB5A-45A1-46BE-B626-03E2B38E0CD6Q38760934-C7A75228-EA89-4DCC-B1C6-72803A3C9DDEQ38771773-778A1BD3-B638-4234-95D1-DB33796A0B05Q49199791-F1E1AB90-DA5F-41CE-B6DB-6DA8FF11F07DQ51748247-253FE44F-B2F0-42C9-AA4F-F928D34D3CDD
P2860
Laminin-332 cleavage by matriptase alters motility parameters of prostate cancer cells.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Laminin-332 cleavage by matriptase alters motility parameters of prostate cancer cells.
@ast
Laminin-332 cleavage by matriptase alters motility parameters of prostate cancer cells.
@en
type
label
Laminin-332 cleavage by matriptase alters motility parameters of prostate cancer cells.
@ast
Laminin-332 cleavage by matriptase alters motility parameters of prostate cancer cells.
@en
prefLabel
Laminin-332 cleavage by matriptase alters motility parameters of prostate cancer cells.
@ast
Laminin-332 cleavage by matriptase alters motility parameters of prostate cancer cells.
@en
P2093
P2860
P356
P1433
P1476
Laminin-332 cleavage by matriptase alters motility parameters of prostate cancer cells
@en
P2093
Alka A Potdar
Brandy Weidow
Daniel Kirchhofer
Hironobu Yamashita
Manisha Tripathi
Vito Quaranta
P2860
P304
P356
10.1002/PROS.21233
P577
2011-02-01T00:00:00Z